US 10995146
Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10995146 (Methods of treating severe insulin resistance by interfering with glucagon receptor signaling) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545